Abrdn PLC Adma Biologics, Inc. Transaction History
Abrdn PLC
- $57.3 Billion
- Q2 2025
A detailed history of Abrdn PLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Abrdn PLC holds 531,782 shares of ADMA stock, worth $8.91 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
531,782Holding current value
$8.91 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
390Shares Held
190MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$312 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$282 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$216 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$192 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$99 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.29B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...